SOX10 Gene
SRY-Box Transcription Factor 10: Key Regulator of Neural Crest Development and Melanocyte Differentiation
Gene Information Card
| Symbol | SOX10 |
|---|---|
| Full Name | SRY-Box Transcription Factor 10 |
| Gene Type | Protein coding |
| Chromosomal Location | 22q13.1 |
| NCBI Gene ID | 6663 ncbi.nlm.nih.gov/gene/6663 |
| Ensembl ID | ENSG00000100146 |
| UniProt ID | P56693 |
| OMIM ID | 602229 |
| HGNC ID | 11190 |
| Aliases | DOM, MGC156697, PCWH, WS4, WS2E, WS4C |
Description
SOX10 (SRY-Box Transcription Factor 10) is a protein-coding gene located on chromosome 22q13.1. It encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and cell fate determination. SOX10 is essential for neural crest cell survival, migration, and differentiation, particularly in melanocytes, glial cells, and enteric neurons. Mutations in SOX10 are associated with Waardenburg syndrome types 2E and 4C, PCWH (peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease), and isolated Hirschsprung disease.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Waardenburg syndrome type 2E | Loss-of-function mutations in SOX10 disrupt melanocyte development, leading to pigmentary abnormalities and sensorineural hearing loss. | ClinVar, OMIM |
| Waardenburg syndrome type 4C (with Hirschsprung disease) | SOX10 mutations impair enteric neuron differentiation, causing aganglionic megacolon (Hirschsprung disease) combined with Waardenburg features. | OMIM, NCBI |
| PCWH syndrome | Dominant-negative or severe loss-of-function mutations in SOX10 cause peripheral neuropathy, central leukodystrophy, Waardenburg syndrome, and Hirschsprung disease. | OMIM, ClinVar |
| Hirschsprung disease (isolated) | Rare SOX10 missense or nonsense variants reduce enteric neural crest cell migration, leading to colonic aganglionosis. | NCBI, ClinVar |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Skin | 12.5 | Medium |
| Brain (cerebellum) | 8.3 | Low |
| Brain (cortex) | 6.1 | Low |
| Adipose tissue | 4.2 | Low |
| Heart | 2.1 | Not detected |
| Liver | 0.8 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SK-MEL-28 (melanoma) | 15.0 | High expression; consistent with melanocyte lineage |
| A375 (melanoma) | 12.3 | High expression |
| SH-SY5Y (neuroblastoma) | 9.5 | Moderate expression |
| HEK293 (embryonic kidney) | 0.5 | Not detected |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.325C>T (p.Arg109*) | Nonsense | Rare | Loss of function; truncation of HMG domain |
| c.482G>A (p.Gly161Asp) | Missense | Rare | Impaired DNA binding; dominant-negative effect |
| c.698_699del (p.Glu233Valfs*12) | Frameshift | Rare | Loss of function; premature termination |
| c.1076delC (p.Pro359Leufs*24) | Frameshift | Rare | Loss of function; associated with PCWH |
Mutation functional classification
Loss of Function (LOF)
Nonsense, frameshift, and splice-site mutations that lead to haploinsufficiency or truncated protein lacking transactivation domain; associated with Waardenburg syndrome type 2E and Hirschsprung disease.
Gain of Function (GOF)
Not reported for SOX10; no activating mutations described in literature or curated databases.
Dominant Negative (DN)
Missense mutations in the HMG domain (e.g., p.Gly161Asp) that retain DNA binding but disrupt transcriptional activation; cause severe PCWH syndrome.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Neural crest differentiation (WP2064)
• Melanogenesis (KEGG hsa04916)
• Signaling pathways regulating pluripotency of stem cells (KEGG hsa04550)
• Transcriptional regulation of white adipocyte differentiation (WP287)
Protein Summary
SOX10 is a 466-amino-acid transcription factor containing a conserved HMG (high-mobility group) DNA-binding domain and a C-terminal transactivation domain. It forms homodimers or heterodimers with other SOX proteins (e.g., SOX9, SOX8) to regulate target genes such as MITF, TYR, and EDNRB. SOX10 is critical for neural crest cell specification, melanocyte survival, and myelination in the peripheral nervous system. Post-translational modifications include phosphorylation and sumoylation, which modulate its transcriptional activity. Mutations in SOX10 cause a spectrum of neurocristopathies, with dominant-negative variants leading to more severe phenotypes.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SOX10 Knockout HEK293 Cell Line | EDJ-KQ5825 | Human | 6663 | Details Get a Quote |
| SOX10 Knockout HeLa Cell Line | EDJ-KQ54539 | Human | 6663 | Details Get a Quote |
| SOX10 Knockout A-549 Cell Line | EDJ-KQ63023 | Human | 6663 | Details Get a Quote |
| SOX10 Knockout HCT 116 Cell Line | EDJ-KQ71499 | Human | 6663 | Details Get a Quote |